HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Mikula Selected Research

high density lipoprotein receptors

3/2019Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma.
1/2018Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation.
8/2015The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Mikula Research Topics

Disease

12Neoplasms (Cancer)
01/2022 - 05/2005
11Melanoma (Melanoma, Malignant)
01/2022 - 06/2010
4Neoplasm Metastasis (Metastasis)
01/2018 - 04/2006
3Carcinogenesis
10/2019 - 10/2003
2Hypoxia (Hypoxemia)
05/2016 - 12/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2007 - 04/2006
1Spontaneous Abortion (Miscarriage)
11/2019
1Habitual Abortion (Recurrent Miscarriage)
11/2019
1Colorectal Neoplasms (Colorectal Cancer)
10/2019
1Colitis
10/2019
1Inflammation (Inflammations)
11/2017
1Tuberous Sclerosis 2
01/2017
1Granuloma
01/2017
1Hypertrophy
01/2017
1Sarcoidosis (Schaumann Disease)
01/2017
1Disease Progression
01/2017
1Sarcoma (Soft Tissue Sarcoma)
10/2016
1Bone Neoplasms (Bone Cancer)
10/2016
1Ewing Sarcoma (Sarcoma, Ewing)
10/2016
1Lung Injury
09/2015
1Pneumonia (Pneumonitis)
09/2015
1Acute Lung Injury
09/2015
1Prostatic Neoplasms (Prostate Cancer)
08/2015
1Hypercholesterolemia
07/2014
1Hyperlipidemias (Hyperlipidemia)
07/2014
1Atherosclerosis
07/2014
1Tuberous Sclerosis (Bourneville's Disease)
03/2012
1Inborn Genetic Diseases (Disease, Hereditary)
09/2011
1Teratoma (Teratoid Tumor)
12/2010
1Ciliopathies
07/2010
1Hepatocellular Carcinoma (Hepatoma)
01/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2009
1Familial Mediterranean Fever (Periodic Disease)
05/2008
1Cystic Fibrosis (Mucoviscidosis)
05/2008

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
11/2016 - 05/2007
4CytokinesIBA
10/2019 - 01/2014
3CholesterolIBA
11/2019 - 08/2015
3Mechanistic Target of Rapamycin Complex 1IBA
10/2019 - 05/2016
3high density lipoprotein receptorsIBA
03/2019 - 08/2015
3Sirolimus (Rapamycin)FDA Link
05/2016 - 07/2014
3Pharmaceutical PreparationsIBA
09/2015 - 06/2010
2HDL LipoproteinsIBA
03/2019 - 01/2018
2Scavenger Receptors (Scavenger Receptor)IBA
03/2019 - 01/2018
2Small Interfering RNA (siRNA)IBA
05/2016 - 03/2012
2TOR Serine-Threonine KinasesIBA
07/2014 - 03/2012
2beta CateninIBA
01/2010 - 01/2007
2Transforming Growth Factor beta (TGF-beta)IBA
01/2010 - 05/2005
2Cadherins (E-Cadherin)IBA
04/2007 - 01/2007
1VemurafenibIBA
01/2022
1ProteomeIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2021
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021
1ProgesteroneFDA LinkGeneric
11/2019
1Mechanistic Target of Rapamycin Complex 2IBA
10/2019
1OsteopontinIBA
10/2019
1STAT5 Transcription FactorIBA
01/2018
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
12/2017
1EnzymesIBA
11/2017
1InterleukinsIBA
11/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2017
1Phosphotransferases (Kinase)IBA
01/2017
1ParaffinIBA
11/2016
1AntibodiesIBA
11/2016
1Cyclin-Dependent Kinase Inhibitor p16IBA
10/2016
1EverolimusFDA Link
09/2015
1Oleic Acid (Oleate)IBA
09/2015
1MTOR InhibitorsIBA
09/2015
1LipopolysaccharidesIBA
09/2015
1dactolisibIBA
09/2015
1Messenger RNA (mRNA)IBA
08/2015
1AndrogensIBA
08/2015
1LDL Receptors (LDL Receptor)IBA
07/2014
1oxidized low density lipoproteinIBA
07/2014
1Surface Antigens (Surface Antigen)IBA
01/2014
1Tetraspanin 30IBA
01/2014
1AntigensIBA
01/2014
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
01/2014
1Cytokine Receptors (Cytokine Receptor)IBA
01/2014
1Nerve Growth Factor (NGF)IBA
01/2014
1Adapalene (Differin)FDA LinkGeneric
01/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2012
1platelet-derived growth factor C (PDGF-C)IBA
08/2012
1Vascular Endothelial Growth Factor CIBA
08/2012
1Tuberous Sclerosis Complex 2 ProteinIBA
03/2012
1Proline (L-Proline)FDA Link
03/2012
1DNA (Deoxyribonucleic Acid)IBA
09/2011
1Biological ProductsIBA
09/2011
1Histone Deacetylase 1IBA
12/2010
1Histone Deacetylases (Histone Deacetylase)IBA
12/2010
1Histone Deacetylase InhibitorsIBA
12/2010
1Indicators and Reagents (Reagents)IBA
12/2010
1StilbenesIBA
06/2010
13,3',4,4',5,5'-hexahydroxystilbeneIBA
06/2010
1IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
06/2009
1Phosphates (Orthophosphate)IBA
06/2009
1Peptide Hydrolases (Proteases)FDA Link
06/2009
1Mannose (D-Mannose)IBA
06/2009
1factor V LeidenIBA
05/2008

Therapy/Procedure

3Therapeutics
01/2022 - 09/2011
1Castration
08/2015